{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T17:15:12Z","timestamp":1783358112168,"version":"3.54.6"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Medicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.clinme.2026.100577","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T04:05:46Z","timestamp":1774929946000},"page":"100577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Renin\u2013angiotensin system inhibitors (RASi) are not nephrotoxic \u2013 they protect the kidneys and the heart"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5979-4664","authenticated-orcid":false,"given":"Jonathan S.","family":"Murray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5288-3074","authenticated-orcid":false,"given":"Paul R.","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5059-3551","authenticated-orcid":false,"given":"Lisa J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas M.","family":"Selby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7960-4573","authenticated-orcid":false,"given":"Simon","family":"Sawhney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2589-1571","authenticated-orcid":false,"given":"William S.","family":"McKane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9500-9080","authenticated-orcid":false,"given":"Marlies","family":"Ostermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin V.","family":"Kolhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0509-7425","authenticated-orcid":false,"given":"Stephen J","family":"McWilliam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Nagalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelagh","family":"Bickerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.P.","family":"Lewington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7534-3688","authenticated-orcid":false,"given":"William T.","family":"Hinchliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Hancock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Kingdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Cockwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1876-3917","authenticated-orcid":false,"given":"Matthew T.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3298-8423","authenticated-orcid":false,"given":"Thomas","family":"Blakeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Morlidge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie A.","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9370-8176","authenticated-orcid":false,"given":"Darren","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinme.2026.100577_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejim.2024.03.021","article-title":"Serum potassium abnormalities, renin-angiotensin-aldosterone system inhibitor discontinuation, and clinical outcomes in patients with chronic cardiovascular, metabolic, and renal conditions: a population-based analysis","volume":"125","author":"Jim\u00e9nez-Marrero","year":"2024","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.clinme.2026.100577_bib2","unstructured":"Recommendations. Chronic kidney disease: assessment and management. Guidance | NICE 2021;\u00a02026."},{"key":"10.1016\/j.clinme.2026.100577_bib3","unstructured":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease."},{"key":"10.1016\/j.clinme.2026.100577_bib4","first-page":"3627","article-title":"2023 Focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"Mcdonagh","year":"2025","journal-title":"Eu\u00a0Heart J"},{"key":"10.1016\/j.clinme.2026.100577_bib5","unstructured":"NHS Business Services Authority. Prescription cost analysis England 2022\/23;\u00a02023."},{"key":"10.1016\/j.clinme.2026.100577_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmacy6020043","article-title":"Comprehension of top 200 prescribed drugs in the us as a resource for pharmacy teaching, training and practice","volume":"6","author":"Fuentes","year":"2018","journal-title":"Pharmacy"},{"key":"10.1016\/j.clinme.2026.100577_bib7","series-title":"Anonymous Healthcare Cost and Utilization Project (HCUP) Statistical Briefs","article-title":"Comorbidities associated with adult inpatient stays, 2019","author":"Owens","year":"2006"},{"key":"10.1016\/j.clinme.2026.100577_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012690","article-title":"Prescription of renin\u2013angiotensin system blockers and risk of acute kidney injury: a population-based cohort study","volume":"6","author":"Mansfield","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.clinme.2026.100577_bib9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s13098-024-01446-1","article-title":"Effect of SGLT-2 inhibitors on acute kidney injury in patients with heart failure: a systematic review and meta-analysis","volume":"16","author":"Wang","year":"2024","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.clinme.2026.100577_bib10","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.kint.2019.07.003","article-title":"Permissive AKI\u201d with treatment of heart failure","volume":"96","author":"Parikh","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.clinme.2026.100577_bib11","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1136\/heartjnl-2018-314158","article-title":"Change in renal function associated with drug treatment in heart failure: national guidance","volume":"105","author":"Clark","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.clinme.2026.100577_bib12","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinme.2026.100577_bib13","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinme.2026.100577_bib14","doi-asserted-by":"crossref","first-page":"953","DOI":"10.7326\/M23-3236","article-title":"Angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers for advanced chronic kidney disease: a systematic review and retrospective individual participant-level meta-analysis of clinical trials","volume":"177","author":"Ku","year":"2024","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinme.2026.100577_bib15","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1056\/NEJMoa2210639","article-title":"Renin\u2013angiotensin system inhibition in advanced chronic kidney disease","volume":"387","author":"Bhandari","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinme.2026.100577_bib16","first-page":"424","article-title":"Stopping renin-angiotensin system inhibitors in patients with advanced CKD and risk of adverse outcomes: a nationwide study","volume":"32","author":"Fu","year":"2021","journal-title":"J\u00a0Am\u00a0Soc\u00a0Nephrol"},{"key":"10.1016\/j.clinme.2026.100577_bib17","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00431-015-2680-8","article-title":"Incidence of and risk factors for severe acute kidney injury in children with heart failure treated with renin\u2013angiotensin system inhibitors","volume":"175","author":"Terano","year":"2016","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.clinme.2026.100577_bib18","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1007\/s00467-021-04920-4","article-title":"Impact of acute kidney injury in patients prescribed angiotensin-converting enzyme inhibitors over the first two years of life","volume":"36","author":"Hirano","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.clinme.2026.100577_bib19","article-title":"Unveiling drug induced nephrotoxicity using novel biomarkers and cutting-edge preventive strategies","volume":"388","author":"D\u017eidi\u0107-Krivi\u0107","year":"2024","journal-title":"Chem-Biol\u00a0Interact"},{"key":"10.1016\/j.clinme.2026.100577_bib20","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1001\/archinte.160.17.2645","article-title":"Are we inhibited?: Renal insufficiency should not preclude the use of ACE inhibitors for patients with myocardial infarction and depressed left ventricular function","volume":"160","author":"Frances","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinme.2026.100577_bib21","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jamainternmed.2018.4749","article-title":"Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with outcomes after acute kidney injury","volume":"178","author":"Brar","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.clinme.2026.100577_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.710228","article-title":"Discharge documentation and follow-up of critically ill patients with acute kidney injury treated with kidney replacement therapy: a retrospective cohort study","volume":"8","author":"Choon","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.clinme.2026.100577_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-020-01659-x","article-title":"Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care","volume":"18","author":"Bidulka","year":"2020","journal-title":"BMC Med"},{"key":"10.1016\/j.clinme.2026.100577_bib24","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/ckj\/sfac003","article-title":"Stopping versus continuing renin\u2013angiotensin\u2013system inhibitors after acute kidney injury and adverse clinical outcomes: an observational study from routine care data","volume":"15","author":"Janse","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.clinme.2026.100577_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12882-016-0430-4","article-title":"Acute kidney injury as an independent risk factor for unplanned 90-day hospital readmissions","volume":"18","author":"Sawhney","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.clinme.2026.100577_bib26","unstructured":"When or if to re-start ACEI, ARB, diuretics and other antihypertensive drugs after an episode of acute kidney injury;\u00a02016."},{"key":"10.1016\/j.clinme.2026.100577_bib27","unstructured":"UK Kidney Association.\u00a0UKKA AKI summit report + recommendations. London: UK Kidney Association; 2024. Available from: \u3008https:\/\/www.ukkidney.org\/sites\/default\/files\/documents\/UKKA%20AKI%20Summit%20Report%20%2B%20Recommendations_compressed.pdf\u3009."},{"key":"10.1016\/j.clinme.2026.100577_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3399\/bjgpopen20X101054","article-title":"Guidance for post-discharge care following acute kidney injury: an appropriateness ratings evaluation","volume":"4","author":"Tsang","year":"2020","journal-title":"BJGP Open"},{"key":"10.1016\/j.clinme.2026.100577_bib29","unstructured":"Recommendations. Chronic kidney disease: assessment and management. Guidance | NICE 2021;\u00a02026."},{"key":"10.1016\/j.clinme.2026.100577_bib30","first-page":"47","article-title":"How to advise on sick day rules","volume":"22","author":"Down","year":"2020","journal-title":"Diabetes Prim Care"},{"key":"10.1016\/j.clinme.2026.100577_bib31","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1053\/j.ajkd.2022.10.012","article-title":"Consensus recommendations for sick day medication guidance for people with diabetes, kidney, or cardiovascular disease: a modified Delphi process","volume":"81","author":"Watson","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clinme.2026.100577_bib32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12875-016-0480-5","article-title":"Preventing acute kidney injury: a qualitative study exploring \u2018sick day rules\u2019 implementation in primary care","volume":"17","author":"Morris","year":"2016","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.clinme.2026.100577_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2017-017241","article-title":"Understanding the implementation of \u2018sick day guidance\u2019 to prevent acute kidney injury across a primary care setting in England: a qualitative evaluation","volume":"7","author":"Martindale","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.clinme.2026.100577_bib34","first-page":"583","article-title":"Usability testing of a sick-day protocol in CKD","volume":"14","author":"Doerfler","year":"2019","journal-title":"Clin\u00a0J\u00a0Am\u00a0Soc\u00a0Nephrol"},{"key":"10.1016\/j.clinme.2026.100577_bib35","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2215\/CJN.14021118","article-title":"Stopping RAS inhibitors to minimize AKI","volume":"14","author":"Tomson","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.clinme.2026.100577_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.xkme.2022.100491","article-title":"Sick day medication guidance for people with diabetes, kidney disease, or cardiovascular disease: a systematic scoping review","volume":"4","author":"Watson","year":"2022","journal-title":"Kidney Med"},{"issue":"9","key":"10.1016\/j.clinme.2026.100577_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.xkme.2022.100527","article-title":"Medication holds in CKD during acute volume-depleting illnesses: a randomized controlled trial of a \u201csick-day\u201d protocol","volume":"4","author":"Fink","year":"2022","journal-title":"Kidney Med"},{"key":"10.1016\/j.clinme.2026.100577_bib38","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/eurheartj\/ehad716","article-title":"Discontinuation vs. continuation of renin-angiotensin system inhibition before non-cardiac surgery: the SPACE trial","volume":"45","author":"Ackland","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinme.2026.100577_bib39","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/jama.2024.17123","article-title":"Continuation vs discontinuation of renin-angiotensin system inhibitors before major noncardiac surgery: the stop-or-not randomized clinical trial","volume":"332","author":"Legrand","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.clinme.2026.100577_bib40","doi-asserted-by":"crossref","first-page":"i1730","DOI":"10.1093\/ndt\/gfaf116.0942","article-title":"Reducing the incidence and severity of acute kidney injury in people with ileostomies\u2014a nurse-led trifecta approach in a district general hospital in the United Kingdom","volume":"40","author":"Bickerton","year":"2025","journal-title":"Nephrol Dial Transpl"}],"container-title":["Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211826000266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211826000266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:23:18Z","timestamp":1783354998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470211826000266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1470211826000266"],"URL":"https:\/\/doi.org\/10.1016\/j.clinme.2026.100577","relation":{},"ISSN":["1470-2118"],"issn-type":[{"value":"1470-2118","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renin\u2013angiotensin system inhibitors (RASi) are not nephrotoxic \u2013 they protect the kidneys and the heart","name":"articletitle","label":"Article Title"},{"value":"Clinical Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinme.2026.100577","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of Royal College of Physicians.","name":"copyright","label":"Copyright"}],"article-number":"100577"}}